Initial studies exploring the ability of Bcl-2 ASO to inhibit leukemia cell survival used a 20-base pair oligonucleotide complementary to the transcription initiation site of Bcl-2 mRNA [52]. This evidence concerns the gene BCL2 and leukemia.